In addition, it should be noted that RAPA has been reported to mitigate GVHD by supporting regulatory T cell expansion [57, 58] and function while inhibiting CD4+ helper cells [59], effector CD8+ T cells [60] and dendritic cells [61]. This evidence concerns the gene CD4 and graft versus host disease.